ACRV Stock Analysis: Buy, Sell, or Hold?
ACRV - Acrivon Therapeutics, Inc. Common Stock
$1.75
0.01 (0.57%)
▲
5d:
-17.84%
30d:
+11.46%
90d:
-5.91%
WAIT
LOW Confidence
Analysis Updated: Jul 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
21d
Get Alerted When ACRV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ACRV is down 17.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ACRV is down 17.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACRV is currently trading at $1.75, which is considered fair relative to its 30-day fair value range of $1.57 to $1.92.
Technical Outlook: Technically, ACRV is in a uptrend. Immediate support is located at $1.69, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+557.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACRV is in a uptrend. Immediate support is located at $1.69, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+557.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.57 -
$1.92
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 557.1% below Wall St target ($11.50)
- WARNING: Recommendation downgraded due to -17.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.57 -
$1.92
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.16
Current Trend
Uptrend
Technical data as of
Jul 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.90
Wall Street Target
$11.50
(+557.1%)
Share & Embed Analysis
Last updated: July 21, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACRV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 51 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$819 | 57 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$262 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 51 HOLD |
